BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26294301)

  • 1. Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.
    Fink JR; Muzi M; Peck M; Krohn KA
    J Nucl Med; 2015 Oct; 56(10):1554-61. PubMed ID: 26294301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
    Pirotte B; Goldman S; Dewitte O; Massager N; Wikler D; Lefranc F; Ben Taib NO; Rorive S; David P; Brotchi J; Levivier M
    J Neurosurg; 2006 Feb; 104(2):238-53. PubMed ID: 16509498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
    J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors.
    Varoquaux A; Rager O; Dulguerov P; Burkhardt K; Ailianou A; Becker M
    Radiographics; 2015; 35(5):1502-27. PubMed ID: 26252192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
    Wray R; Solnes L; Mena E; Meoded A; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):423-30. PubMed ID: 26099676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
    Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
    J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
    Ohno Y; Koyama H; Yoshikawa T; Nishio M; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Maniwa Y; Nishio W; Nishimura Y; Itoh T; Sugimura K
    Radiology; 2011 Nov; 261(2):605-15. PubMed ID: 21926377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced MR Imaging in Pediatric Brain Tumors, Clinical Applications.
    Lequin M; Hendrikse J
    Neuroimaging Clin N Am; 2017 Feb; 27(1):167-190. PubMed ID: 27889022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors.
    Overcast WB; Davis KM; Ho CY; Hutchins GD; Green MA; Graner BD; Veronesi MC
    Curr Oncol Rep; 2021 Feb; 23(3):34. PubMed ID: 33599882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of PET/MR, focused on clinical applications.
    Catalano OA; Masch WR; Catana C; Mahmood U; Sahani DV; Gee MS; Menezes L; Soricelli A; Salvatore M; Gervais D; Rosen BR
    Abdom Radiol (NY); 2017 Feb; 42(2):631-644. PubMed ID: 27624499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
    Galldiks N; Langen KJ
    Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
    Walter F; Cloughesy T; Walter MA; Lai A; Nghiemphu P; Wagle N; Fueger B; Satyamurthy N; Phelps ME; Czernin J
    J Nucl Med; 2012 Mar; 53(3):393-8. PubMed ID: 22323780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain tumors: a multimodality approach with diffusion-weighted imaging, diffusion tensor imaging, magnetic resonance spectroscopy, dynamic susceptibility contrast and dynamic contrast-enhanced magnetic resonance imaging.
    Brandão LA; Shiroishi MS; Law M
    Magn Reson Imaging Clin N Am; 2013 May; 21(2):199-239. PubMed ID: 23642551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality assessment of brain tumors and tumor recurrence.
    Heiss WD; Raab P; Lanfermann H
    J Nucl Med; 2011 Oct; 52(10):1585-600. PubMed ID: 21840931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical PET/MR Imaging in Dementia and Neuro-Oncology.
    Henriksen OM; Marner L; Law I
    PET Clin; 2016 Oct; 11(4):441-52. PubMed ID: 27593248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.